G protein-activated inward rectifier potassium channel 4 — Drug Target

All drugs that target G protein-activated inward rectifier potassium channel 4 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

High Risk QT Prolonging Agents

Marketed (1)

• Norpace Cr · Pfizer · High Risk QT Prolonging Agents · Cardiovascular
  Norpace is a sodium channel blocker and a Class 1a anti-arrhythmic agent.